Role of Inflammasome Activation in Tumor Immunity Triggered by Immune Checkpoint Blockers

Clinical and Experimental Immunology - United Kingdom
doi 10.1111/cei.13433
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Inflammasome Activation and Innate Immunity in Alzheimer's Disease

Brain Pathology
Forensic MedicineNeurosciencePathologyNeurology
2017English

Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases

Journal of Immunology
AllergyImmunology
2019English

Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors

Frontiers in Oncology
Cancer ResearchOncology
2019English

Sensitization to Immune Checkpoint Blockade Through Activation of a STAT1/NK Axis in the Tumor Microenvironment

Science Translational Medicine
Medicine
2019English

An NLRP3 Inflammasome–triggered Th2-Biased Adaptive Immune Response Promotes Leishmaniasis

Journal of Clinical Investigation
Medicine
2015English

Role of Tissue-Resident Memory in Intra-Tumor Heterogeneity and Response to Immune Checkpoint Blockade

Frontiers in Immunology
AllergyImmunology
2018English

Trousseau's Syndrome Triggered by an Immune Checkpoint Blockade in a Non-Small Cell Lung Cancer Patient

European Journal of Immunology
AllergyImmunology
2018English

Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Role of Immune Checkpoint Inhibitors in Gastrointestinal Cancer Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy